Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients
Annals of Neurology · 2024-09 · 96 (3) · 453-459
DOI: 10.1002/ana.27027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 04.07.2024. Verfasst von Matthew R Brier und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Multiple Sclerosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NINDS NIH HHS, Gerald and Henrietta Rauenhorst Foundation.
Abstract (Originalsprache)
The life expectancy of people with multiple sclerosis (MS) has increased, yet we have noted that development of a typical Alzheimer disease dementia syndrome is uncommon. We hypothesized that Alzheimer disease pathology is uncommon in MS patients. In 100 MS patients, the rate of amyloid‐β plasma biomarker positivity was approximately half the rate in 300 non‐MS controls matched on age, sex, apolipoprotein E proteotype, and cognitive status. Interestingly, most MS patients who did have amyloid‐β pathology had features atypical for MS at diagnosis. These results support that MS is associated with reduced Alzheimer disease risk, and suggest new avenues of research. ANN NEUROL 2024;96:453–459
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
- Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- C2N Diagnostics, St. Louis, MO, USA.
ORCID-Profile: Matthew R Brier, Amber Salter, Sarah Keefe, Brian A Gordon, Tammie L S Benzinger, Anne H Cross
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- Gerald and Henrietta Rauenhorst Foundation
- Alzheimer's Drug Discovery Foundation
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
Zitieren
APA
Brier, M. R., Schindler, S. E., Salter, A., Perantie, D., Shelley, N., Judge, B., Keefe, S., Kirmess, K. M., Verghese, P. B., Yarasheski, K. E., Venkatesh, V., Raji, C. A., Gordon, B. A., Bateman, R. J., Morris, J. C., Naismith, R. T., Holtzman, D. M., Benzinger, T. L. S., & Cross, A. H. (2024). Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients. Annals of Neurology, 96(3), 453-459. https://doi.org/10.1002/ana.27027
Vancouver
Brier MR, Schindler SE, Salter A, Perantie D, Shelley N, Judge B, et al. Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients. Annals of Neurology. 2024;96(3):453-459. doi:10.1002/ana.27027
BibTeX
@article{Brier2024,
author = {Brier, Matthew R and Schindler, Suzanne E and Salter, Amber and Perantie, Dana and Shelley, Nicole and Judge, Bradley and Keefe, Sarah and Kirmess, Kristopher M and Verghese, Philip B and Yarasheski, Kevin E and Venkatesh, Venky and Raji, Cyrus A and Gordon, Brian A and Bateman, Randall J and Morris, John C and Naismith, Robert T and Holtzman, David M and Benzinger, Tammie L S and Cross, Anne H},
title = {Unexpected Low Rate of Amyloid‐β Pathology in Multiple Sclerosis Patients},
journal = {Annals of Neurology},
year = {2024},
volume = {96},
number = {3},
pages = {453--459},
doi = {10.1002/ana.27027}
}
EUVIMED